426 related articles for article (PubMed ID: 25442675)
1. BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts.
Schweizer L; Capper D; Hölsken A; Fahlbusch R; Flitsch J; Buchfelder M; Herold-Mende C; von Deimling A; Buslei R
Neuropathol Appl Neurobiol; 2015 Oct; 41(6):733-42. PubMed ID: 25442675
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia.
Jones RT; Abedalthagafi MS; Brahmandam M; Greenfield EA; Hoang MP; Louis DN; Hornick JL; Santagata S
Mod Pathol; 2015 Apr; 28(4):596-606. PubMed ID: 25412847
[TBL] [Abstract][Full Text] [Related]
3. Rathke's cleft cysts: differentiation from other cystic lesions in the pituitary fossa by use of single-shot fast spin-echo diffusion-weighted MR imaging.
Kunii N; Abe T; Kawamo M; Tanioka D; Izumiyama H; Moritani T
Acta Neurochir (Wien); 2007 Aug; 149(8):759-69; discussion 769. PubMed ID: 17594050
[TBL] [Abstract][Full Text] [Related]
4. BRAF V600E mutation is a useful marker for differentiating Rathke's cleft cyst with squamous metaplasia from papillary craniopharyngioma.
Kim JH; Paulus W; Heim S
J Neurooncol; 2015 May; 123(1):189-91. PubMed ID: 25820214
[No Abstract] [Full Text] [Related]
5. Distinct patterns of primary and motile cilia in Rathke's cleft cysts and craniopharyngioma subtypes.
Coy S; Du Z; Sheu SH; Woo T; Rodriguez FJ; Kieran MW; Santagata S
Mod Pathol; 2016 Dec; 29(12):1446-1459. PubMed ID: 27562488
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological study of Rathke's cleft cysts.
Ikeda H; Yoshimoto T
Clin Neuropathol; 2002; 21(2):82-91. PubMed ID: 12005257
[TBL] [Abstract][Full Text] [Related]
7. TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology.
Liu Y; Wang CH; Li DL; Zhang SC; Peng YP; Peng JX; Song Y; Qi ST; Pan J
Oncotarget; 2016 Aug; 7(31):50564-50574. PubMed ID: 27409178
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous alteration from Rathke's cleft cyst to craniopharyngioma--possible involvement of transformation between these pathologies.
Ogawa Y; Watanabe M; Tominaga T
Endocr Pathol; 2014 Dec; 25(4):422-6. PubMed ID: 25154633
[TBL] [Abstract][Full Text] [Related]
9. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral Rathke's Cleft Cyst Remnants Within Craniopharyngioma, Pituitary Adenoma, Suprasellar Dermoid, and Epidermoid Cysts: A Ubiquitous Signature of Ectodermal Lineage or a Transitional Entity?
Manjila S; Asmar NE; Vidalis BM; Alonso F; Singh G; Vadamalai K; Cohen ML; Bambakidis NC; Arafah BM; Selman WR
Neurosurgery; 2019 Aug; 85(2):180-188. PubMed ID: 30010935
[TBL] [Abstract][Full Text] [Related]
11. EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts.
Thimsen V; Hölsken A; Buchfelder M; Flitsch J; Fahlbusch R; Stefanits H; Losa M; Jones DT; Buslei R
Sci Rep; 2016 Jul; 6():29731. PubMed ID: 27431859
[TBL] [Abstract][Full Text] [Related]
12. Targeted BRAF and CTNNB1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells.
Marucci G; de Biase D; Zoli M; Faustini-Fustini M; Bacci A; Pasquini E; Visani M; Mazzatenta D; Frank G; Tallini G
Pituitary; 2015 Dec; 18(6):905-11. PubMed ID: 26156055
[TBL] [Abstract][Full Text] [Related]
13. Rathke's Cleft Cyst as Origin of a Pediatric Papillary Craniopharyngioma.
Schlaffer SM; Buchfelder M; Stoehr R; Buslei R; Hölsken A
Front Genet; 2018; 9():49. PubMed ID: 29520296
[TBL] [Abstract][Full Text] [Related]
14. [Asymptomatic and symptomatic Rathke's cleft cysts. Histological study of 45 cases].
Keyaki A; Hirano A; Llena JF
Neurol Med Chir (Tokyo); 1989 Feb; 29(2):88-93. PubMed ID: 2475810
[TBL] [Abstract][Full Text] [Related]
15. Craniopharyngioma arising in a Rathke's cleft cyst: case report.
Alomari AK; Kelley BJ; Damisah E; Marks A; Hui P; DiLuna M; Vortmeyer A
J Neurosurg Pediatr; 2015 Mar; 15(3):250-4. PubMed ID: 25555112
[TBL] [Abstract][Full Text] [Related]
16. Rathke's Cleft Cyst and Craniopharyngioma: A Continuum of the Same Spectrum? Insights from an Interesting Case and Previous Literature.
Sharma R; Meena R; Ganeshkumar A; Narwal A; Doddamani R; Singh M; Chandra SP
Neurol India; 2024 Mar; 72(2):403-407. PubMed ID: 38691485
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
[TBL] [Abstract][Full Text] [Related]
18. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.
Capper D; Preusser M; Habel A; Sahm F; Ackermann U; Schindler G; Pusch S; Mechtersheimer G; Zentgraf H; von Deimling A
Acta Neuropathol; 2011 Jul; 122(1):11-9. PubMed ID: 21638088
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of operated Rathke's cleft cysts with special reference to re-accumulation and recommended surgical strategy.
Ogawa Y; Watanabe M; Tominaga T
Acta Neurochir (Wien); 2011 Dec; 153(12):2427-33; discussion 2433. PubMed ID: 21725869
[TBL] [Abstract][Full Text] [Related]
20. [Magnetic resonance imaging characteristics and differential diagnosis of common sellar cystic lesions].
Liu H; Lu X; Hang W; Liu G
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Nov; 54(11):819-825. PubMed ID: 31795542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
